Cite
HARVARD Citation
Gao, L. et al. (2023). Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial. Diabetes, obesity & metabolism. 25 (3), pp. 785-795. [Online].